Archer Aviation, which will test its eVTOLs over Los Angeles this year, plans a “vertiport” at AEG’s L.A. Live, next to the Lakers’ arena and city convention center.
AI can help a business do more without doing more of everything. The founders getting real value from it are using it to protect what makes their business worth building.
The Kushner scion’s VC firm Thrive Capital nearly tripled its assets thanks to smart bets on OpenAI and SpaceX. Now he’s looking to spend some cash on the NBA’s Lakers.
Whether you’re chasing fall colors or fewer crowds, these national parks offer some of the best autumn travel experiences in the country.
AI’s big debt load. Moving backward on defense tech. Why we need to talk about CPUs. All that and more in this week’s Prototype.
The Chinese-owned social network has been flooded with advertisements pushing street drugs and prescription pills like codeine, benzos and Adderall.
For four generations, Rome’s Angelini family has built a $2.5 billion operation with drugs for depression and epilepsy in Europe. Now it’s bought its way into the U.S. market.
In this week’s edition of InnovationRx, we look at Summa Health’s first tech bets, the healthcare leaders on Forbes Veteran 250 list, BioMarin’s acquisition of an early-stage bone disease therapy, and more.
Despite racking up more than $2 billion in losses while sticking to a do-it-yourself strategy, buy-now, pay-later pioneer Affirm is finally profitable—and worth $25 billion.
Chairman and CEO Wang Xingxing’s fortune surged nearly sevenfold to $16 billion as investors bet on China’s leading humanoid robot maker.